prexasertib small molecule checkpoint kinase inhibitor mainly active minor activity causes induction dna doublestrand breaks resulting apoptosis developed eli lilly company announced dropping prexasertib active although clinical trials continue research continues efficacy prexasertib treatment acute myeloid leukemia myelodysplastic syndrome rhabdomyosarcoma httpsenwikipediaorgwikiprexasertib